Neoadjuvant Therapy Use Rising Sharply in Cancer Care

Published Date: 26 Feb 2026

The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.

Read Full News

Todays Updates


Worsening Heart-Kidney-Metabolic Health May Threaten Vision


People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

Common Epilepsy Drug Tied to Increased Glaucoma Risk


Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis


In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease.

Study Maps Extensive Disease Links Beyond Childhood Eczema


Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

Two Biologics Show Comparable Benefit in Uveitis


Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis.

Metabolic Syndrome Tied to Glaucoma Risk


Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening.

New Rx Option for Neuromyelitis Optica Spectrum Disorder?


Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder.

Todays Updates


Worsening Heart-Kidney-Metabolic Health May Threaten Vision


People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

Common Epilepsy Drug Tied to Increased Glaucoma Risk


Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis


In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease.

Study Maps Extensive Disease Links Beyond Childhood Eczema


Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

Two Biologics Show Comparable Benefit in Uveitis


Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis.

Metabolic Syndrome Tied to Glaucoma Risk


Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening.

New Rx Option for Neuromyelitis Optica Spectrum Disorder?


Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

2.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

3.

Additional Proof of the Different Cognitive Effects of ARSIs for Prostate Cancer.

4.

What Patients Hear From Us: 'Blah, Blah, Tumor, Blah, Blah, Cancer'

5.

FDA Expands Approval of Osimertinib in Lung Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot